Han Yisheng

Han Yisheng


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
GCGuihua Cao
Guihua Cao
JYJinhong Yan
Jinhong Yan
XNXiaoxuan Ning
Xiaoxuan Ning
QZQi Zhang
Qi Zhang
QWQi Wu
Qi Wu
JGJianbin Guo
Jianbin Guo

1 June 2018 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
JYJin-Hong Yan
Jin-Hong Yan
CWChun-Hui Wang
Chun-Hui Wang
KLKe-Wen Li
Ke-Wen Li
QZQi Zhang
Qi Zhang
MYMin Yang
Min Yang
HYHan Yisheng
Han Yisheng
Background and objective: The modulus of carbon fiber-reinforced polyether ether ketone (CFR-PEEK), a composite containing layers of carbon fiber sheets, can be precisely controlled to match bone. However, CFR-PEEK is biologically inert and cannot promote bone apposition. The objective of this study was to investigate whether graphene modification could enhance the bioactivity of CFR-PEEK. Methods and results: In vitro, the proliferation and differentiation of rat bone marrow stromal cells on scaffolds were quantified via cell-counting kit-8 assay and Western blotting analysis of osteoblast-specific proteins. Graphene modification significantly promoted bone marrow stromal cell proliferation and accelerated induced differentiation into osteogenic lineages compared to cells seeded onto nongraphene-coated CFR-PEEK. An in vivo rabbit extraarticular graft-to-bone healing model was established. At 4, 8, and 12 weeks after surgery, microcomputed tomography analyses and histological observations revealed significantly better microstructural parameters and higher average mineral apposition rates for graphene-modified CFR-PEEK implants than CFR-PEEK implants (P<0.05). van Gieson staining indicated more new bone was formed around graphene-modified CFR-PEEK implants than CFR-PEEK implants. Conclusion: Graphene may have considerable potential to enhance the bioactivity and osseointegration of CFR-PEEK implants for clinical applications.

1 March 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
QZQi Zhang
Qi Zhang
KLKewen Li
Kewen Li
JYJinhong Yan
Jinhong Yan
ZWZhuo Wang
Zhuo Wang
QWQi Wu
Qi Wu
HYHan Yisheng
Han Yisheng

1 October 2021 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
JGJianbin Guo
Jianbin Guo
GCGuihua Cao
Guihua Cao
XWXing Wang
Xing Wang
WTWenhao Tang
Wenhao Tang
WDWeilong Diwu
Weilong Diwu
HYHan Yisheng
Han Yisheng
Introduction: With increases in implant infections, the search for antibacterial and biofilm coatings has become a new interest for orthopaedists and dentists. In recent years, graphene oxide (GO) has been extensively studied for its superior antibacterial properties. However, most of these studies have focused on solutions and there are few antibacterial studies on metal surfaces, especially the surfaces of cobalt-chromium-molybdenum (CoCrMo) alloys. ϵ-Poly-L-lysine (ϵ-PLL), as a novel food preservative, has a spectrum of antimicrobial activity; however, its antimicrobial activity after coating an implant surface is not clear. Methods: In this study, for the first time, a two-step electrodeposition method was used to coat GO and ϵ-PLL on the surface of a CoCrMo alloy. Its antibacterial and antibiofilm properties against S. aureus and E. coli were then studied. Results: The results show that the formation of bacteria and biofilms on the coating surface was significantly inhibited, GO and ϵ-PLL composite coatings had the best antibacterial and antibiofilm effects, followed by ϵ-PLL and GO coatings. In terms of classification, the coatings are anti-adhesive and contact-killing/inhibitory surfaces. In addition to oxidative stress, physical damage to GO and electrostatic osmosis of ϵ-PLL are the main antibacterial and antibiofilm mechanisms. Discussion: This is the first study that GO and ϵ-PLL coatings were successfully prepared on the surface of CoCrMo alloy by electrodeposition. It provides a promising new approach to the problem of implant infection in orthopedics and stomatology.

7 August 2025 in International Journal of Surgery Protocols
Verified
Journal Article
Open access
WDWeilong Diwu
Weilong Diwu
WTWenhao Tang
Wenhao Tang
MYMing Yan
Ming Yan
WMWenrui Ma
Wenrui Ma
HYHan Yisheng
Han Yisheng
MYMin Yang
Min Yang
Background: Postoperative pain management remains a critical determinant of functional recovery following total knee arthroplasty (TKA). While local infiltration analgesia (LIA) is commonly employed, its clinical utility is limited by inconsistent analgesic duration (median duration of 8–12 hours), technical variability among surgeons, and systemic toxicity risks associated with high-volume injections. This phase II randomized controlled trial evaluates a dual-optimization strategy combining anatomic mapping-guided periarticular cutaneous nerve (PCN) blockade with a sustained-release triamcinolone-ropivacaine formulation to address these limitations. Method: In this single-center, assessor-blinded, 2 × 2 factorial design, 120 adults undergoing primary unilateral TKA were randomized to four intervention arms: Group 1: Conventional iPACK (interspace between the popliteal artery and posterior knee capsule) site + novel formulation (1% ropivacaine + 40 mg triamcinolone); Group 2: PCN block site + standard formulation (1% ropivacaine + 5 mg dexamethasone); Group 3: PCN block + novel formulation; Group 4: Control (iPACK + standard formulation). Triamcinolone acetonide replaces dexamethasone in the new formulation due to its prolonged anti-inflammatory effect and demonstrated efficacy in periarticular analgesia. Primary endpoints included: resting/movement-induced pain intensity (Visual Analog Scale) at 6, 24, and 48 h postoperatively, cumulative opioid consumption (morphine milligram equivalents), functional recovery metrics (knee flexion angle, Timed Up-and-Go test). Secondary outcomes assessed safety through adverse event rates (infection, neurologic symptoms, hemodynamic instability). Conclusions: Anatomic mapping-guided PCN blockade combined with triamcinolone-ropivacaine formulation significantly improves postoperative analgesia and functional outcomes compared to conventional LIA techniques. This dual-optimization approach may redefine periarticular infiltration standards in TKA, particularly for patients at high risk of opioid-related complications.